MINNEAPOLIS--(BUSINESS WIRE)--Urologix®, Inc. (NASDAQ:ULGX), today reported financial results for the fiscal 2007 second quarter ended December 31, 2006. Revenue for the second quarter was $6.0 million compared to $5.4 million reported in the first quarter of fiscal 2007 and $6.5 million in the second quarter of fiscal 2006. During the second quarter, average selling prices remained comparable to those in the prior quarter while catheter sales to direct accounts drove the 11 percent sequential improvement in overall revenue.
